Skip to content
    Calculus Capital logo

    Calculus Capital

    London, United KingdomFounded 1999
    calculuscapital.comLinkedIn
    Biotech & Life SciencesHealthcareMedia & EntertainmentFintechSaaSClimate & Energy

    Calculus Capital is a London-based venture capital firm founded in 1999, specializing in tax-efficient investment solutions through Enterprise Investment Scheme (EIS) and Venture Capital Trust (VCT) funds. The firm invests in innovative, high-growth UK companies across sectors including technology, healthcare, life sciences, and media.

    They made 5 investments in the last 12 months. Average disclosed round size is $17.4M (across 6 rounds with reported amounts).

    Find people at Calculus Capital on Goldilocks AI

    Portfolio

    25

    Fund Size

    —

    Top Stage

    Series A

    Last 12 Mo

    2

    Team

    Arvind Shandilya

    Arvind Shandilya

    Assistant Investment Director

    Brad Noel

    Brad Noel

    Assistant Director, Media and Entertainment Financing

    Christopher Gould

    Christopher Gould

    Assistant Director, Media and Entertainment Financing

    Elizabeth Klein

    Elizabeth Klein

    Investment Director

    Francesca Rayneau

    Francesca Rayneau

    Director, Head of Sales and Marketing

    Frank Spurway

    Frank Spurway

    Assistant Director, Sales & Marketing

    Mariyah Dosani

    Mariyah Dosani

    Director - Media and Entertainment Financing

    Matthew Moynes

    Matthew Moynes

    Director, Sales & Marketing

    Natalie Evans

    Natalie Evans

    Finance Director

    Oliver Warren

    Oliver Warren

    Director, Sales & Marketing

    William Prince

    William Prince

    Director, Finance and Fund Administration

    Aitian Li

    Aitian Li

    Investment Associate

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    31 investments
    CompanyRoundAmountDate
    Trogenix logoTrogenixSeries A—Oct 2025
    TTrogenixSeries A$70MOct 2025
    Ensilitech logoEnsilitechSeed—Aug 2025
    LLaverock TherapeuticsSeed—Jun 2025
    Laverock logoLaverockSeed—Jun 2025
    WWorkLSeries A—Jan 2024
    Arctic Shores logoArctic ShoresSeries B—Jan 2023
    Wazoku logoWazokuSeries B—Sep 2022
    Axol Bioscience logoAxol BioscienceUnknown—Apr 2022
    Rotageek logoRotageekSeed—Jan 2022
    MMip DiagnosticsUnknown—Jul 2020
    Invizius logoInviziusSeries A—Apr 2018
    CCloudTradeUnknown—Jan 2018
    MMip DiagnosticsSeries A—Jan 2018
    SSynpromicsUnknown—Apr 2017
    SSynpromicsUnknown—Jan 2017
    SSynpromicsUnknown—Jan 2015
    MMoney DashboardSeed$3.7MNov 2014
    MMoney DashboardSeed$4.4MNov 2013
    Tagomics logoTagomicsPre-Seed——
    Resurrect Bio logoResurrect BioSeries A$8.1M—
    Blu Wireless logoBlu WirelessGrowth$16.6M—
    Wazoku logoWazokuGrowth——
    Oxford BioTherapeutics logoOxford BioTherapeuticsUnknown——
    Notify Technology logoNotify TechnologyGrowth——
    Page 1 of 2

    Top Co-Investors

    Mercia Asset Management5 shared
    Eli Lilly and Company4 shared
    Scottish Investment Bank4 shared
    Eos Advisory3 shared
    IQ Capital3 shared
    4BIO Capital2 shared
    Cancer Research Horizons2 shared
    Brain Tumor Investment Fund2 shared
    LongeVC2 shared
    Future Planet Capital2 shared
    Crowdcube2 shared
    Mercia2 shared
    Penny Jar Capital1 shared
    Gaingels1 shared
    Empirical Ventures1 shared
    #ANGELS1 shared
    Beringea1 shared
    Praetura Ventures1 shared
    Scottish Enterprise Growth Investment Team1 shared
    Gresham House1 shared

    Last updated: 8 September 2026